Searchable abstracts of presentations at key conferences in endocrinology

ea0090p256 | Thyroid | ECE2023

Non-secreting pheochromocytoma or adrenal metastasis of medullary thyroid cancer? When the differential diagnosis is difficult

Bouchenna Amira , Kablia Samia Ould

Introduction: Medullary thyroid cancer (MTC) accounts for 5-10% of thyroid cancers.25% of cases may be hereditary related to multiple endocrine neoplasia type 2 A (MEN2A) and associated with pheochromocytoma. Metastases from CMT are preferentially lymph node chains. However, other localizations are possible such as adrenal metastases which remain exceptional.Observation: We report the case of a 35-year-old patient with CMT for which he underwent thyroide...

ea0090p802 | Thyroid | ECE2023

Graves’ disease associated with thymic hyperplasia: about a case

Bouchenna Amira , Kablia Samia Ould

Introduction: The association between Graves’ disease and thymic hyperplasia was first described in 1912. Hundreds of cases have since been described. This rare association doesn’t seem fortuitous. We report a case.Observation: A 30-year-old patient with no particular personal history who consults following the onset of dyspnea with chest tightness. A CT scan of the chest revealed thymic hyperplasia. The preoperative assessment found an hyperth...

ea0081ep622 | Endocrine-Related Cancer | ECE2022

Refractory papillary thyroid carcinoma treated with sorafenib: an Algerian experience

Bouchenna Amira , Tibouk Abdelghani , Brahim Ghennam , Samia Ould Kablia

Introduction: 5-10% of papillary thyroid carcinoma develop metastatic disease, of which about 60-70% will become refractory to radioactive iodine. Significant negative impact on the prognosis and an average life expectancy of 3 to 5 years.Material and method: Since 2018, patients with refractory thyroid carcinoma and considered to be progressive according to the RECIST criteria have been treated with anti tyrosine Kinase type sorafenib.<p class="abst...

ea0081ep1146 | Thyroid | ECE2022

Papillary carcinoma of the thyroid associated with Marine-Lenarth syndrome: about a case

Bouchenna Amira , Tibouk Abdelghani , Brahim Ghennam , Samia Ould Kablia

Introduction: The Marine-Lenhart syndrome (MLS) is commonly defined as a combination of Graves’ disease and autonomous functioning thyroid nodule (s). the risk of malignancy of these nodules is less than 1% We report a case.Observation: 27-year-old patient, hospitalized for treatment of a basal disease, cervical ultrasound found a 1.5 cm lower left lobe thyroid nodule classified eutirads 4. the sintigraphy found an aspect of diffuse hypercaptive goi...

ea0090ep1040 | Thyroid | ECE2023

Hashitoxicosis : a case report

Hanane Brahimi , Bouchenna Amira , Sara Lamara-Mohamed , Samia Ouldkablia

Introduction: Autoimmune thyroid diseases are frequent and very polymorphic pathologies. The same person can successively present with different manifestations. Graves’ disease and Hashimoto’s thyroiditis seem to be able to coexist. The name "Hashitoxicosis" has been suggested in this case, characterized by the sequential association, whatever the order, of hyper- and hypothyroidism. We report in this work, the case of a patient treated for autoimmune hypothy...

ea0090ep1065 | Thyroid | ECE2023

Diagnosis and management of a thyrotoxicosis storm on unknown hyperthyroidism

Hanane Brahimi , Somia Fetouci , Bouchenna Amira , Samia Ouldkablia

Introduction : In the spectrum of endocrine emergencies, thyroid storm is one of the most critical complications. Recognition and appropriate management of life-threatening thyrotoxicosis is vital to prevent the high morbidity and mortality that may accompany this disorder. The incidence of thyroid storm has been noted to be less than 10% of patients hospitalized for thyrotoxicosis; however, the mortality rate secondary to thyroid storm ranges from 20 to 30%. We report in this...

ea0063p351 | Thyroid 1 | ECE2019

Anaplastic thyroid carcinoma or radiation-induced sarcoma: About a case

Amira Bouchenna , Abdelghani Tibouk , Youcef Bakkouche , Samia Ould Kablia

Introduction: Anaplastic thyroid cancer has long been considered as a mesenchymal tumor (sarcoma). To date, it is difficult to differentiate between the two types. Radio-induced sarcomas of the head and neck are a very rare entity. Their annual incidence is 0.06 to 0.17%.Observation: We report the case of a 83-year-old patient, with a history of breast neoplasia treated with radiotherapy 7 years ago. Followed for a year for papillary carcinoma of the thy...

ea0092ps2-14-04 | Case Reports 1 | ETA2023

Diagnosis and management of a thyrotoxicosis storm on unknown hyperthyroidism

Hanane Brahimi , Bouchenna Amira , Somia Fetouci , Ouldkablia Samia

Introduction: In the spectrum of endocrine emergencies, thyroid storm is one of the most critical complications. Recognition and appropriate management of life-threatening thyrotoxicosis is vital to prevent the high morbidity and mortality that may accompany this disorder. The incidence of thyroid storm has been noted to be less than 10% of patients hospitalized for thyrotoxicosis; however, the mortality rate secondary to thyroid storm ranges from 20 to 30%. We report in this ...

ea0081ep20 | Adrenal and Cardiovascular Endocrinology | ECE2022

Adrenal hemangioma with subclinical cushing’s syndrome

Samia Ould Kablia , Benfiala Mouna , Katia Benabdelatif , Kassa Reda , Bouchenna Amira

Introduction: Adrenal cavernous hemangioma is a rare tumor with few cases reported in the world. Usually this adrenal masses are incidentally discovered and non functional.Case report: We describe the case of a 63 year old male patient with a history of hypertension and treated prostate. He was referred to our endocrinology department with complaints of his left lower back. At the admission the BMI was 21 kg/m2, his blood pressure was 160/90 m...

ea0090ep212 | Calcium and Bone | ECE2023

Severe proximal myopathy revealed a primary hyperparathyroidism: about a case and literature review

Katia Benabdelatif , Lachkhem Aicha , Yahi Abdelkader , Bouchenna Amira , Samia Ould Kablia

Introduction: Proximal myopathy presents as symmetrical weakness of proximal upper and/or lower limbs. There is a broad range of underlying causes including drugs, alcohol, endocrine and metabolic myopathies such as primary hyperparathyroidism.Observation: We describe a 48-year-old male, hospitalised in neurology departement for exploration of severe proximal myopathy. Cliniquely, he presented progressive debilitating muscle weakness, severe muscle wasti...